Entellus Medical, Inc.
USPTO PatentsView assignee record - 55 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Entellus ranks #6,139 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 7 technology areas.
- #6,139
- of 49,997 US assignees by volume
- Top 38%
- by Innovation Score (39.4/100)
- 18.1
- avg claims per patent
- +4%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6139 · US Corporation #6,139 · 55 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL
- GRANTS-SMALL 55 grants
- UPPER-Q #6,139/49,997
- PHOTO-FINISH East Carolina…
- CPC-NARROW A61B · 7 areas
- INNOV-THIN 39.4/100
- CLAIMS-RICH 18.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-FLAT +4% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: East Carolina University (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Entellus’s 39.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Entellus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Assa Abloy Accessori… · near
Assa Abloy Accessori… · near
39 score
- Entellus Medical · this assignee
Entellus Medical · this assignee
39 score
- Vyaire Medical Capital · near
Vyaire Medical Capital · near
39 score
- Xiamen Galenpoo… · near
Xiamen Galenpoo… · near
39 score
- uBiome · near
uBiome · near
39 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Entellus's Innovation Score is 39.4/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Entellus?
Each dot is one of Entellus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Entellus’s own 18.1 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Entellus's grants concentrate
Entellus Medical, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 94.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2016 (10 grants) versus a trough of 1 in 2022. By volume, Entellus sits between Enzo Life Sciences, Inc. and FMC Kongsberg Subsea AS.
Entellus's three-year grant acceleration
Entellus Medical, Inc. shows 15 grants in 2022–2024 against only 19 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Entellus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Enzo Life Sciences
Enzo Life Sciences, Inc.
55 patents
- Eugene Technology
Eugene Technology Co., Ltd.
55 patents
- East Carolina Uni…
East Carolina University
55 patents
- Ellenberger & Poe…
Ellenberger & Poensgen GmbH
55 patents
- Erasmus Universit…
Erasmus University Medical Center Rotterdam
55 patents
- Exo Imaging
Exo Imaging, Inc.
55 patents
- Floricultura B V
Floricultura B.V.
55 patents
- FMC Kongsberg Sub…
FMC Kongsberg Subsea AS
55 patents
- Entellus Medical ◀
Entellus Medical, Inc.
55 patents
What this shows Entellus holds 55 patents at rank #6,141, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Entellus
By rank, the assignees closest to #6,141 in granted patent volume.
- Enzo Life Sciences, Inc. #6,137 · 55 patents
- Eugene Technology Co., Ltd. #6,138 · 55 patents
- East Carolina University #6,139 · 55 patents
- Ellenberger & Poensgen GmbH #6,140 · 55 patents
- Erasmus University Medical Center Rotterdam #6,142 · 55 patents
- Exo Imaging, Inc. #6,143 · 55 patents
- Floricultura B.V. #6,144 · 55 patents
- FMC Kongsberg Subsea AS #6,145 · 55 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Entellus's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Entellus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Entellus ranks #361 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (39 here).
Similar claim depth
Nearest assignees by average claims per patent (18.1 here).
Entellus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 38% higher than 62% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 7.3% |
| 2016 | 10 | 18.2% |
| 2017 | 4 | 7.3% |
| 2018 | 3 | 5.5% |
| 2019 | 6 | 10.9% |
| 2020 | 4 | 7.3% |
| 2021 | 9 | 16.4% |
| 2022 | 1 | 1.8% |
| 2023 | 8 | 14.5% |
| 2024 | 6 | 10.9% |
Which technologies does Entellus Medical, Inc. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Entellus Medical, Inc.'s patent record in context - here's where to go next.
- Entellus Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 94.5% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #6,139 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Entellus Medical, Inc. against Enzo Life Sciences, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.